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Purpose: The aim of this study is to determine the incidence of Clostridium difﬁcile infection (CDI) in an
Australian hospital and highlight considerations for other Asian countries that are considering establishing or modifying existing CDI surveillance programs.
Methods: An observational study design with dynamic population was used. Data from all persons
hospitalized for more than 48 hours over 4 years in a tertiary hospital in Australia were analyzed. Persons
with healthcare associated, healthcare facility onset CDIs were identiﬁed. The calculation of the relative
risk was performed to compare the occurrence of CDI in different groups.
Results: Of the total 58,942 admissions examined, 158 admissions had CDI. The incidence of CDI per
1,000 admissions for the entire study period was 2.68 (95% conﬁdence interval [2.28, 3.13]). There was a
statistically signiﬁcant increase in the incidence of CDI in 2010 compared to that of 2007 (p < .001). The
incidence of CDI increased from the 30e39-year age group onwards.
Conclusion: Comparisons between this study and others are challenging due to the lack of standardized
deﬁnitions for CDI internationally. Noting the increases of CDI internationally and the associated mortality, there is increasing importance to monitor and report the incidence of this infection worldwide.
Copyright © 2014, Korean Society of Nursing Science. Published by Elsevier. All rights reserved.
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Introduction
Clostridium difﬁcile, a bacterium that is a common cause of
diarrhea in hospitalized patients, can cause a variety of infections,
ranging from mild diarrhea to pseudomembranous colitis. The
incidence and severity of C. difﬁcile infection (CDI) is increasing
around the world, particularly in the northern hemisphere (Collins,
Hawkey, & Riley, 2013). The primary mode of transmission of
C. difﬁcile is person to person via the fecal-oral route (National
Health and Medical Research Council, 2010). C. difﬁcile can exist
in vegetative or spore form, with spores acting as a reservoir for
transmission, particularly in the healthcare environment via the
healthcare workers’ hands (Dumford, Nerandzic, Eckstein, &
Donskey, 2009; Stuart & Marshall, 2011). The ingestion of the organism does not necessarily result in infection due to the protective
effects of the colonic ﬂora (Cartman, Heap, Kuehne, Cockayne, &
Minton, 2010). Disruption of the normal ﬂora can occur following
exposure to antibiotics, chemotherapy, antiperistaltic drugs, and
gastroenterological surgery (Cartman et al., 2010; Kassavin, Pham,
Pascarella, Yen-Hong, & Goldfarb, 2013; Kuijper, Coignard, & Tull,
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2006). Antibiotics are thought to be an important risk factor for CDI,
with a large number of studies supporting the association between
antibiotics and CDI (Pepin, Valiquette, & Cossette, 2005; Polgreen
et al., 2007; Thomas, Stevenson, & Riley, 2003).
Diagnosis of CDI occurs through the testing of fecal samples at a
microbiology laboratory. The laboratory diagnosis of CDI is made
through the detection of C. difﬁcile by culture and/or by detection of
its toxins. Treatment for symptomatic CDI usually involves stopping
the use of antibiotics where possible and/or prescribing either
vancomycin or metronidazole. Prevention of CDI primarily consists
of three elements. First, appropriate antibiotic usage, including
correct administration, is important. Second, early instigation and
continued use of CDI prevention and control strategies, such as
isolation of symptomatic persons, can assist in preventing the
spread within a healthcare environment. Third, ensuring high
standards of environmental cleanliness in healthcare settings can
assist in the prevention and control of CDI (Van Gessel, Riley, &
McGregor, 2009). Nurses play a key role in each of these three
strategies. The importance of these measures and the ways to understand the risks that CDI pose to patients are best demonstrated
through studies examining mortality.
Recent literature examining mortality and CDI indicates that CDI
has a signiﬁcant adverse effect on hospitalized patients (Karas,
Enoch, & Aliyu, 2010; Mitchell & Gardner, 2012; Mitchell,
Gardner, & Hiller, 2013). In two reviews examining this topic,
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only one study examining CDI and mortality in an Asian setting was
found. Furthermore, there have been limited studies published in
English that described the incidence of CDI in Asia (Collins et al.,
2013). Studies investigating the incidence and mortality of CDI in
settings outside of Europe and North America are needed so that
the epidemiology of CDI in these regions can be understood with
appropriate interventions planned. This paper describes a study
exploring the incidence of CDI in a large Australian hospital. It also
highlights important considerations for other Asian countries that
are considering establishing or modifying existing CDI surveillance
programs. In addition, it is hoped that by highlighting this infection
in an Asian journal, it will encourage others to publish in this area
and address the current gap in epidemiological knowledge in the
region.
Methods
The aim of this study is to determine the incidence of CDI between January 1st, 2007 and December 30th, 2010 in an Australian
hospital.
Study design
To address the research questions, a retrospective observational
design with dynamic population is used.
Setting and sample

Prevention and Control Unit [TIPCU]), the Infection Prevention and
Control Unit at the hospital, and a review of the patient administration system and medical records of each person who has CDI
during the period.
To identify the population, all admissions aged 2 years and older
who were admitted to the hospital for more than 48 hours were
identiﬁed by the clinical coding department at the request of the
researcher. To allow for the identiﬁcation of persons who developed CDI during their hospital stay, the TIPCU provided the
researcher with details on all admissions who had an episode of CDI
occurring at the hospital during the study period, consistent with
the case deﬁnitions described earlier. Using the data provided by
the TIPCU, further data were collected through a review of the records held on the hospital patient information system and on the
individual medical records of those with CDI. The review of the
medical records of each patient with CDI included reviewing
medical and nursing documentation related to the frequency of
diarrhea.
The Infection Prevention and Control Unit at the hospital
collected data within the timeframe that a person with CDI was
isolated under contact precautions. The researcher reviewed the
data provided by this unit for when persons with CDI had contact
precautions ceased. The rationale for using the cessation of contact
precautions as a marker for infection cessation is described in more
detail in the following section. Data using this process were only
available from July 1st, 2009 until December 30th, 2010, as the
infection control unit did not collect this data prior to July 1st, 2009.
There were 11 instances within this timeframe where data were not
available from the hospital infection control unit. Subsequently, a
review of the medical notes of these admissions was conducted and
pointed to the date a person was removed from isolation. Data on
the isolation periods of a total of 72 persons (from July 1st, 2009 to
December 30th, 2010) were obtained.

All persons aged 2 years or older and who were hospitalized at a
tertiary referral hospital in Australia for more than 48 hours between January 1st, 2007 and December 31st, 2010 formed the study
population. Persons in the study population are referred to as
“admissions” throughout this paper. The hospital is a 500-bed
hospital that provides a full range of services including an emergency department, intensive care, surgery, renal, children, chemotherapy and maternity services.
From the available data, those persons who developed CDI
during their hospital stay were subsequently identiﬁed. A person
was deﬁned as having CDI if he or she had a positive stool sample
result for C. difﬁcile using either a laboratory assay (enzyme
immunoassay or polymerase chain reaction) detecting toxin A and/
or toxin B or culture, resulting in the isolation of C. difﬁcile that is
subsequently shown to produce toxin A and/or toxin B. The positive
stool sample had to be collected more than 48 hours after admission to capture cases of healthcare-associated healthcare facility
onset episodes of CDI (McDonald et al., 2007). All infectious episodes included in this study were such episodes. Any positive stool
sample for C. difﬁcile occurring in patients less than 2 years old or
occurring within 8 weeks of the last positive test was excluded.
During the full study period, the microbiology department
tested all diarrheal samples from the hospitalized patients,
regardless of reason for hospitalization for C. difﬁcile. Diarrhea was
deﬁned as an unformed stool that took the shape of the container.

The data items collected included date of birth, sex, age,
admission and discharge date, date of infection, date of infection
cessation and the diagnosis-related group. The issue of deﬁning CDI
cessation in an individual is challenging. As C. difﬁcile may continue
to be detected from asymptomatic colonization, laboratory testing
for the clearance of CDI is not recommended (Stuart et al., 2011).
The researcher undertook a review of 20 medical notes of admissions with CDI and found that medical records failed to document a
formed stool or cessation of diarrhea reliably. Based on the ﬁndings
from the review of the 20 medical records, it was considered that
the cessation of contact precautions for persons with CDI was a
simple, reliable, and practical method of determining the cessation
of CDI and was consistent with literature (National Health and
Medical Research Council, 2010). Additionally, the decision to
cease contact precautions was made after a review done by an
infection control professional at the time of making this clinical
decision.

Ethical considerations

Data analysis

Ethical approval for this research was granted by two human
research ethics committees (Tasmanian Human Research Ethics
Committee and Australian Catholic University).

Descriptive analysis on the characteristics of the admissions was
performed using IBM SPSS Version 20.0 (International Business
Machines Corporation, 2011). Distributions were analyzed using
QeQ plots and the KolmogoroveSmirnov test. Univariate analysis
was used to compare the clinical characteristics of persons with and
without CDI using a chi-square test or Fisher’s exact test where
numbers were small. Incidence for calendar years and age groups
was calculated by using mid p exact test. The calculation of the
relative risk was performed to compare the occurrence of CDI in

Data collection
Data were retrieved from four different sources. These sources
comprised data from the clinical coding department at the hospital,
a government surveillance unit (The Tasmanian Infection

Data items collected
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different groups. Conﬁdence interval (CI) was calculated using
Taylor series.
Results
Population size and incidence of infection
During the study period, there were 58,942 admissions of persons aged 2 years and older who stayed for 48 hours or longer at the
Royal Hobart Hospital. These 58,492 admissions equated to a total
of 493,626 bed days, deﬁned as the sum of each individual person’s
length of stay in the hospital. The total number of admissions per
annum at the hospital increased from 14,055 in 2007 to 15,185 in
2010, representing an 8% increase over the 4 years. Within this 4year period, the largest seasonal increase in admissions occurred
in spring, with a total of 16.5% more persons being admitted in 2010
compared to 2007.
There were 158 admissions with an episode of CDI in the calendar years 2007e2010. Despite removing duplicate samples
occurring within 8 weeks of the previous positive samples, there
were ﬁve instances of a secondary infection occurring in the same
person during the 4-year study period. Further analysis of these ﬁve
instances suggests that secondary cases were unrelated to the ﬁrst
case.
The annual incidence of CDI per 1,000 admissions for the calendar years 2007e2010 ranged from 1.71 (95% CI [1.12, 2.50]) to
3.89 (95% CI [2.96, 5.01]). The incidence of CDI per 1,000 admissions
for the entire study period was 2.68 (95% CI [2.28, 3.13]). There was
a statistically signiﬁcant increase in the incidence of CDI in 2010
compared to that of 2007 (p < .001).
Demographic characteristics of study population
The distribution of age for the study population was not normal:
D (58, 784) ¼ 0.08, p < .001 (KolmogoroveSmirnov test). As the size
of the study is large, the distribution of age was conﬁrmed as nonnormally distributed using QeQ plots. Table 1 displays the age and
sex characteristics of the admissions.
Age stratiﬁcation, which examined the incidence of CDI per
1,000 admissions, was performed. The results displayed in Figure 1
and Table 2 demonstrate the incidence of CDI by age group. The

Table 1 Demographic Characteristics of Those With and Without Clostridium difﬁcile
Infection (CDI).
Characteristic

Sex
Male
Female
Intersex
Not speciﬁed
Age (yr)
Median
Range
Age group
2e9
10e19
20e29
30e39
40e49
50e59
60e69
70e79
80e89
 90

Total
(N ¼ 58,942)

Admissions that
developed CDI
(n ¼ 158)
n (%)

Admissions that did not
develop CDI
(n ¼ 58,784)
n (%)

79 (50.0)
79 (50.0)
e
e

25,915 (44.1)
32,857 (55.9)
11 (< 1%)
1 (< 1%)

25,994
32,936
11
1

67
2e102

55
2e106

55
2e106

3 (1.9)
6 (3.8)
3 (1.9)
5 (3.2)
13 (8.2)
24 (15.2)
31 (19.6)
38 (24.1)
30 (19.0)
5 (3.2)

1,523
3,471
7,977
6,928
5,748
6,759
8,609
9,159
7,057
1,553

1,526
3,477
7,980
6,933
5,761
6,783
8,640
9,197
7,087
1,558

(2.6)
(5.9)
(13.6)
(11.8)
(9.8)
(11.5)
(14.6)
(15.6)
(12.0)
(2.6)

(2.6)
(5.9)
(13.5)
(11.8)
(9.8)
(11.5)
(14.7)
(15.6)
(12.0)
(2.6)
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incidence of CDI increases from the 30e39 year age group until the
80e89 year age group. The incidence of CDI stratiﬁed by sex and
age group is provided in Table 2.
The probability of a person admitted to the hospital during the
study period as having CDI relative to their age group is displayed in
Table 3. In calculating the relative risks displayed in Table 3, reference groups used were persons aged less than the stated age
groups. Results are displayed in this manner to demonstrate the
graduating relative risk. The graduating relative risk displayed in
this manner can inform a decision as to the age groups CDI surveillance should be performed.
Comparisons were made between the diagnosis-related group
categories assigned to persons with and without CDI. Signiﬁcantly,
more persons with the diagnosis-related group categories “nervous”, “digestive”, “kidney”, and “neoplastic” diseases had CDI
compared to persons without these categories did (p < .01).
Conversely, those persons with diagnosis-related group categories
of “mental health” and “pregnancy” were signiﬁcantly less likely to
have CDI (p < .01).
Timing, duration of infection and documentation
For admissions that had an episode of CDI, the median time to
infection from admission was 8 days, with a range of 2e104 days
(75th percentile ¼ 13 days). Available data on the length of time
admissions had infection was incomplete. After reviewing information held by the Infection Prevention and Control Unit at the
hospital and the medical and nursing notes, the time an admission
was in isolation in hospital was only identiﬁed for 72 of the 158
instances of infection. For these 72 infections, the median time an
admission had CDI was 5 days, with a range of 1e47 days. Twentyﬁve per cent of these admissions had CDI for 11 days or more. For
admissions with CDI, there was limited information regarding the
frequency of diarrhea in the medical and nursing notes. The use of a
tool to measure the type and frequency of diarrhea was not found.
Discussion
In this study, an increasing incidence of CDI was found, with a
signiﬁcant increase between 2007 and 2010. These ﬁndings are
consistent with reports published by the TIPCU and other published
literature of healthcare-associated healthcare facility onset CDI in
Tasmania (Mitchell, McGregor, Wells, & Wilson, 2012). When
comparing the incidence of CDI between organizations or countries, it is important to consider the methodological inﬂuences that
affect the reliability and validity of the data (Mitchell & Gardner,
2014a). In the case of CDI, the study duration, denominator selection, testing effort, and testing methodology lead to ascertainment
bias (Mitchell, Ware, McGregor, Brown, & Wells, 2011). With this in
mind, there have been calls to standardize CDI testing and surveillance methods internationally (Mitchell et al., 2011). For countries yet to establish CDI surveillance or for those currently
developing such programs, it is vital that they consider these
points. This is particularly important in the Asian region, where CDI
surveillance is still in its infancy.
The value of having standardized deﬁnitions for CDI and other
healthcare associated infections cannot be underestimated. If
healthcare associated infections data are used to underpin infection
prevention programs and strategies, it is imperative that the data
are collected and reported using consistent and reproducible
methods (Mitchell & Gardner, 2014b). Failure to do so will make the
evaluation of interventions to reduce healthcare associated infections more challenging, as it will be difﬁcult to decipher the
impact of interventions against the effect of issues, such as changes
in the testing methodologies and testing efforts.
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Figure 1. Incidence of Clostridium difﬁcile infection per annum by age group. Error bars denote 95% conﬁdence intervals.

Table 2 Incidence of Clostridium difﬁcile Infection Stratiﬁed by Sex and Age Group.
Characteristic

Incidence per 1,000 admissions

95% conﬁdence interval

1.34
1.34

1.07e1.66
1.07e1.66

1.97
1.73
0.38
0.72
2.26
3.54
3.59
4.13
4.23
3.21

0.40e5.74
0.63e3.76
0.08e1.99
0.23e1.68
1.20e3.86
2.27e5.27
2.44e5.09
2.92e5.67
2.85e6.04
1.04e7.49

Sex
Male
Female
Age group (yr)
2e9
10e19
20e29
30e39
40e49
50e59
60e69
70e79
80e89
 90

Table 3 Comparison of Relative Risk of Clostridium difﬁcile Infection (CDI) by Age
Group.
Age group (yr)a









80
70
60
50
40
30
20
10

Incidence

Admissions that
developed CDI / Admissions

RR

95% CIb

4.06
4.11
3.94
3.86
3.63
3.19
2.77
2.71

35 / 8,610
73 / 17,769
104 / 26,378
128 / 33,137
141 / 38,885
146 / 45,813
149 / 53,790
155 / 57,261

1.66
1.98
2.36
3.29
4.23
3.44
3.53
1.36

1.14e2.40
1.44e2.70
1.70e3.27
2.21e4.90
2.56e7.00
1.91e6.19
1.80e6.88
0.43e4.24

Note. RR ¼ relative risk; CI ¼ conﬁdence interval.
a
Reference group are persons aged less than the stated age group.
b
Conﬁdence interval is calculated using Taylor series.

The incidence of CDI in our study appears to be higher than that
reported in other Australian hospitals (Van Gessel, 2008). There is,
however, limited data with which to compare the incidence of CDI
in Australia. Internationally, it can be noted that the incidence
found in this study is lower than that reported in many CDI surveillance systems in Europe and North America. In England, the
reported rate for 2009e2010 was 3.7 per 10,000 bed days, down
from 5.5 per 10,000 bed days in 2008e2009 (Health Protection
Agency, 2011). It is important to note, however, that only samples
from persons hospitalized for 4 days or more are reported in this
ﬁgure for the English surveillance scheme. If this criterion is applied

to this study, the incidence of CDI will reduce by approximately 16%,
down to 2.26 per 1,000 admissions or 2.69 per 10,000 patient days.
This demonstrates the importance of paying attention to the
exclusion criteria when comparing CDI data and the need for a
more standardized approach (Freeman et al., 2010). The higher
incidence of CDI is not only seen with England, Scotland and Germany also reported higher rates of CDI (7.6 and 4.7 per 10,000
occupied bed days, respectively) (Gastmeier, Weitzel-Kage, Behnke,
& Eckmanns, 2009; Health Protection Scotland, 2011). Conversely,
there have been lower reported incidence rates of CDI in other
European countries, such as Belgium (1.52 per 1,000 admissions)
(Viseur, Lambert, Delmee, Van Broeck, & Catry, 2011) and the
Netherlands (1.8 per 1,000 admissions) (Hensgens, Goorhuis,
Notermans, van Benthem, & Kuijper , 2009). In North America, an
incidence of 22.5 cases of CDI per 1,000 admissions has been reported (Loo et al., 2005), with more recent studies demonstrating
an increasing incidence of CDI (Chandler, Hedberg, & Cieslak, 2007;
Kazakova et al., 2006; Tan et al., 2007). Data on the incidence of CDI
in Asia is limited (Collins et al., 2013). Noting the increases of CDI
internationally and the associated mortality (Karas et al., 2010;
Mitchell et al., 2013), there is increasing importance to monitor
and report the incidence of this infection worldwide, particularly in
Asia (Collins et al.; Ekma, Yee, & Aziz, 2012).
Issues relating to variations in laboratory testing and the potential impact that these have in research and in surveillance have
been discussed earlier. There are two important factors to be taken
into account when considering whether an increase in the incidence of CDI is “real”. These are testing effort and testing methodology. Testing effort refers to how many stool samples received
by a laboratory are tested for CDI. This is dependent on what criteria
are used before a test for CDI is performed. In this study, all diarrheal samples from the hospitalized individuals were tested for
C. difﬁcile during the study period, so this is unlikely to have a role
in the calculated increase of CDI. However, the process of testing for
CDI can vary considerably among institutions. For example, private
microbiology laboratories may only test for C. difﬁcile if the test is
requested. This has the risk of ascertainment bias and is not often
accounted for in CDI surveillance (Freeman et al., 2010). Testing
methodology or the sensitivity of testing can play a role in identifying cases of CDI. In this study, the methodologies used for testing
for C. difﬁcile were highly sensitive and, in all situations, the laboratory testing for the C. difﬁcile toxin used an assay. Therefore, the
increase in healthcare-associated healthcare facility onset CDI over
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time was unlikely to have been caused by changes in the testing
effort or testing methodology. Alternatively, given the rigorous
testing, there is also little chance of underestimation of infection in
this study.
The ﬁndings from this study suggest that the incidence of CDI
increases with age, from 30 years old up until the age of 90. The
reason for the incidence of CDI not continuing to increase past 90
years of age is almost certainly an artifact of the small number of
admissions with CDI occurring in this age group in this study.
Consistent with this study, increasing age is a well-established risk
factor for CDI (DuPont, Garey, Caeiro, & Jiang, 2008; McDonald,
Owings, & Jernigan, 2006). A variation in the proportion of a hospitalized population that is older may affect the incidence of CDI
(McFarland, Surawicz, & Stamm, 1990; Starr, Martin, McCoubrey,
Gibson, & Poxton, 2003; Vaishnavi, 2009). Internationally, there
are some surveillance programs that speciﬁcally focus on CDI in
persons aged 65 years and over. For example, in both England and
Wales, the incidence of CDI in persons aged 65 and over is higher
than in all persons aged 2 years and over (Health Protection Agency,
2011; Welsh Healthcare Associated Infection Programme, 2011).
Data extrapolated from the Health Protection Agency suggest that
the relative risk for CDI was 2.27 (p < .001, 95% CI [2.20, 2.34]),
comparing those aged 65 and over to those aged less than 65 years
in England (Health Protection Agency).
The trend of a higher incidence of CDI in persons aged 65 and
older is repeated in this study, which reports an incidence of 4.22
per 1,000 admissions (95% CI [3.41, 5.16]) for this age group. The
relative risk of CDI in persons aged 65 and over in this study,
compared to persons less than 65 years old, is 2.42 (p < .001, 95% CI
[1.75, 3.38]), a similar ﬁnding to the CDI surveillance in England. In
this study, the relative risks for CDI by age group are also compared
for each decade of life. The groups with the highest relative risk are
persons aged 40 years and older compared to persons who are less
than 40 years old. It is not possible to calculate the relative risk for
CDI in different age groups for England and Wales based on the
available data. Nonetheless, the ﬁndings of this study pose the
question as to whether the “65 and over” age group is the most
appropriate age group for targeted CDI surveillance because it appears that the risk of contracting CDI begins to increase signiﬁcantly for patients as young as 40 years of age. This has clear
implications for countries establishing or considering modiﬁcations
to existing CDI surveillance programs.
Results from this study also suggest that the median time to
infection from admission was 8 days. For nurses, this highlights the
importance of being aware of the signs and symptoms of CDI
around this period, particularly for susceptible or at risk groups.
Prompt isolation of patients with diarrhea and early specimen
collection will reduce the risk of transmission and lead to the opportunity for early diagnosis and treatment. Upon reviewing the
medical and nursing notes of persons with CDI in this study, poor
standards of documentation were found. Speciﬁcally, there was a
lack of documentation describing patients’ symptoms, such as
diarrhea. Standardized tools are available for describing diarrhea,
for example the Bristol Stool Chart (Lagrotteria, Holmes, Smieja,
Smaill, & Lee, 2006). The type of stool and frequency of diarrhea
are important pieces for decision making for infection control
professionals and clinicians and nurses standards of documentation can go a long way to improving this situation.
Implications
There are several implications of this study for practice, future
research and policy. For policy, this study demonstrates the need
for using standardized deﬁnitions for CDI and to survey an entire
hospital population for CDI, not just those in more advanced age
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groups. These points should be considered for those planning or
modifying CDI surveillance programs. The paper identiﬁed the risk
of CDI increasing with advancing age. Future research could
examine what speciﬁc host factors related to advancing age
contribute most to this increased risk. For clinical practice, this
study demonstrates the impact CDI can have and support prevention and control measures, often led by nurses. These could include
but not be limited to antibiotic stewardship (Charani & Holmes,
2013), maintaining standards of environmental cleanliness
(Rutala & Weber, 2013) and the early identiﬁcation and isolation of
patients suspected of having CDI.
Conclusion
The incidence of CDI found in this study is lower than those
reported in most countries in the northern hemisphere but higher
than those reported from limited Australian data. The increase in
CDI is part of a trend experienced internationally in recent years.
These points are signiﬁcant as the author’s ﬁndings suggest that the
impact of CDI is not yet fully realized in Australia or more widely
across Asia due to limited published data. We may yet experience
increases in CDI as have occurred in other countries. In order to
better interpret the trends and the epidemiology of CDI, the issue of
variations in microbiological testing methodologies becomes an
important issue. Differences in the testing methodologies make
comparisons intrinsically difﬁcult and there is a need for standardized practice in this area internationally. When planning or
modifying CDI surveillance programs, testing methodologies
should be understood to better determine the limitations of the
program and subsequent interpretation of the results. Results from
this study found that the risk of CDI increases with age. However,
not all surveillance programs survey the population at most risk.
Surveillance of CDI should include those aged 2 years and over,
rather than be limited to older adults. In so doing, the population at
most risk will be surveyed and appropriate health and infection
prevention and control interventions can be implemented.
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